PRP studies for lumbar discs often omitted key reporting details
A review examined reporting completeness in studies of platelet-rich plasma (PRP) injections, leaving treatment effectiveness and safety unresolved by its main analysis.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review found incomplete reporting in studies of PRP injections for lower-back disc conditions. Its main outcome was how fully papers described treatments and methods. Missing information makes benefits and harms harder to evaluate; the adherence percentage describes reporting completeness and does not measure patients' pain relief.
The checklist was adapted from MIBO. The abstract does not detail individual omissions or risk-of-bias findings, and this abstract-based explanation cannot establish the quality of every treatment result.
What researchers found
Mean reporting completeness
For papers published January 2016–June 2024, the average percentage of required items reported, measured against a 46-item adapted MIBO checklist.
What the checklist assessed
Researchers checked papers using a reporting checklist for biologic treatments in orthopaedics, known as MIBO. More complete descriptions help readers assess transparency and whether others could reproduce the research methods.
Guidelines and reporting practice
The review described similar reporting completeness before and after the guidelines appeared. That comparison does not establish that publishing guidance caused any change; the authors called for closer adherence to improve research transparency.
The original publication
Poor Adherence to the Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) Guidelines for Clinical Studies on Platelet-rich Plasma for Lumbar Disc Pathologies: A Systematic Review.
Robert G, Butler JJ, Tishelman J et al.
Clin Orthop Relat Res · 2026
- PubMed ID
- 41290406
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.